Previous close | 68.15 |
Open | 68.87 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 68.15 - 68.87 |
52-week range | 63.17 - 84.60 |
Volume | |
Avg. volume | 240 |
Market cap | 35.287B |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 15.96 |
EPS (TTM) | 4.27 |
Earnings date | 31 Jul 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
As part of an expanded partnership announced last August, Cognizant (NASDAQ: CTSH) has launched the first set of healthcare large language model (LLM) solutions on Google Cloud's generative AI (genAI) technology, including the company's Vertex AI platform and Gemini models, aimed at redesigning healthcare administrative processes and improving experiences.
Cognizant (NASDAQ: CTSH) (the "Company") today announced it has signed a definitive agreement to acquire Belcan, LLC ("Belcan"), a portfolio company of AE Industrial Partners and a leading global supplier of Engineering Research & Development (ER&D) services, at a purchase price of approximately $1.3 billion in cash and stock, subject to customary adjustments.
Cognizant (NASDAQ: CTSH) is teaming up with Nexthink to transform enterprise digital experience operations with Cognizant's WorkNEXT™ platform. Under the agreement, Cognizant will apply its deep expertise in digital workplace services and its portfolio of tools with Nexthink's flagship product, Nexthink Infinity, to create a new joint offering, Cognizant WorkNEXT™ Workplace Intelligence.